• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

76.4500 SEK 1.2500 1.66%

As of 11:30:00 ET on 12/17/2014.

Company Profile for Swedish Orphan Biovitrum AB (SOBI)

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Contact Information

Swedish Orphan Biovitrum AB

Berzelius vaeg 8
Stockholm, SE-12276
Sweden
Phone: 46-8-697-20-00
Fax: 46-8-697-23-30

Key Executives for Swedish Orphan Biovitrum AB (SOBI)

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
Hege HellstromVP/Head:CommercialDennis PedersenSenior VP/Head:MFG Ops
Fredrik BergVP/Gen Cnsl/Head:Legal & IPStefan FraenkelVP/Head:Corporate Development
Stephen JamesVP/Head:Drug Design & DevCecilia ForbergVP/Head:Project & Portfolio
Anders EdvellVP/Head:Sobi Partner ProductsJorgen WinrothVP/Head:Investor Relations
Wills Hughes-WilsonVP:External Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil